Single-active microencapsulated powder designed for light, heat and oxidation sensitivity and poor powder dispersibility. Assay per finished-product specification; immediate / non-modified.
Technical summary
Product code NG-MIC-003
Choose an evaluation sample or listed pack where available. Use Request a Quotation for commercial supply and Request Technical Documents for controlled product information.
For business buyers. Product-specific documentation and availability are confirmed for each enquiry.
How the sample programme worksProduct information
Review the key specifications at a glance, then expand only the sections you need.
Single-active microencapsulated powder designed for light, heat and oxidation sensitivity and poor powder dispersibility. Assay per finished-product specification; immediate / non-modified.
Microencapsulated Lycopene supplies Lycopene in a food-grade protective microencapsulation matrix. It is intended as an independent formulation module for professional B2B use. Product-specific identity, assay, physical, microbiological, contaminant and stability controls are defined in the finished-product specification and verified by batch CoA.
| Product ID / order SKU | NG-MIC-003 |
|---|---|
| Technology | Microencapsulation |
| Product type | Microencapsulated Powder |
| Current status | Qualification and availability confirmed per enquiry |
| Active / marker | Lycopene |
| Assay / loading | Per finished-product specification |
| Delivery system | food-grade protective microencapsulation matrix |
| Release type | Immediate / non-modified |
| Evaluation sample | 50 g — €40 ex VAT |
| Commercial MOQ | Confirmed per quotation |
| Pack sizes | 1 kg; 5 kg; 25 kg |
| Lead time | Confirmed per quotation |
| Active ingredient | Lycopene |
|---|---|
| Chemical / nutrient form | Lycopene |
| Assay / loading | Per finished-product specification |
| Assay method | Approved product-specific analytical method |
| Carrier / wall material | Food-grade protective wall matrix / carrier |
| Delivery system | food-grade protective microencapsulation matrix |
| Release behaviour | Immediate / non-modified |
| Particle size d10 | Per specification |
| Particle size d50 | Per specification |
| Particle size d90 | Per specification |
| Mesh range | Per specification |
| Bulk density | Per specification |
| Tapped density | Per specification |
| Moisture / loss on drying | Per specification |
| Water activity | Per specification |
| Solubility | Product-specific; see TDS |
| Dispersibility | Product-specific; see TDS |
| Flowability | Per finished-product specification |
| Appearance / colour | Product-specific; see TDS |
| Odour | Product-specific; see TDS |
| Taste | Product-specific; see TDS |
| pH | Not applicable unless specified |
| Microbiological limits | Per finished-product microbiological specification |
| Heavy-metals limits | Per finished-product heavy-metals specification |
| Residual solvents | Complies with finished-product specification |
| Oxidation markers | Product-specific oxidation or degradation markers per finished specification |
| Other critical specification | Immediate availability and product-specific protection performance |
| Shelf life | Per current stability documentation |
| Component | Function | Public composition information |
|---|---|---|
| Lycopene | Active ingredient | Product-specific qualified source; Per finished-product specification; Finished-product specification |
| Food-grade protective wall matrix / carrier | Microencapsulation, protection and powder handling | Qualified food-grade source; q.s. to 100%; Controlled composition; exact proprietary composition is confidential |
Country of origin is stated in the controlled Country of Origin Statement. Supplier and manufacturing-site information are not published.
A protective wall matrix is used to address light, heat and oxidation sensitivity and poor powder dispersibility; the product remains immediate/non-modified release.
capsules, tablets, premixes and functional foods
| Test / study | Result summary | Evidence |
|---|---|---|
| Identity and assay confirmation | Conforms to approved specification | Current commercial batch; Batch CoA |
| Immediate availability / protection performance | Meets approved immediate-availability and functional-performance criteria | Representative batch; Dissolution / Release Data |
| Stability / shelf-life support | Meets approved stability criteria through the documented period | Representative stability batches; Stability Documentation |
Store tightly closed in original packaging in a cool, dry place, protected from heat, moisture and direct light Free-flowing powder with product-specific colour and odour; see TDS and batch CoA.
The current product-specific document set is confirmed for each enquiry according to qualification status, the applicable manufacturer and relevant batch. Controlled composition, characterisation or performance details may require an NDA where specified.
| Target market | European Union / EEA |
|---|---|
| Intended use | Food supplements and professional formulation use; final suitability depends on dose and application |
| Ingredient legal status | Product-specific ingredient-level information can be confirmed; the customer must verify intended use and national requirements |
| Novel food review | Product-specific regulatory-status information is confirmed on request |
| Carrier / additive compliance | All carriers, wall materials and coating components reviewed for the intended product scope |
| Maximum / recommended use level | Set by customer formulation, applicable law and product-specific technical guidance |
| Label declaration | Lycopene |
| Allergen declaration | Declare according to the current product-specific allergen statement |
| Origin declaration | See Country of Origin Statement |
| Nutrition / health claim relevance | Finished-product nutrition or health claims are the customer’s responsibility |
| Technical claim / statement | Microencapsulated powder supporting light, heat and oxidation sensitivity and poor powder dispersibility; immediate/non-modified release. |
| Evidence supporting statement | TDS, specification, stability, immediate-availability and product-specific performance data |
| Medicinal / disease wording check | Passed: no medicinal or disease-treatment wording |
| Regulatory approval status | Ready for product-specific website approval |
No medicinal, disease-treatment or finished-product health claim is made. No sustained, delayed, enteric or targeted-release claim is made. Finished-product classification, dose, permitted use, label declarations, nutrition or health claims and market compliance remain the customer’s responsibility.
Which documentation can be requested? The current product-specific document set is confirmed on request according to qualification status, the applicable manufacturer and relevant batch. Where available, product-specific information supports the stated non-modified-release positioning.
May be combined with other independent NexaGens formulation modules after compatibility and finished-product validation.
Immediate / non-modified.
For professional B2B food, food-supplement and formulation use only. Not for direct consumer use.
Request the current technical, quality, stability and compliance documents for this ingredient.
Review the formulation challenges most relevant to this ingredient before requesting evaluation material or documentation.
View all microencapsulated ingredients